| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,860 | 2,935 | 08:37 | |
| 2,865 | 2,925 | 07:30 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.05. | Oryzon Genomics, S.A.: ORYZON to Provide Corporate Progress Updates at Several Events in May-June | ||
| 26.05. | ORYZON GENOMICS, S.A.: Call of the Ordinary General Shareholders' Meeting of Oryzon Genomics, S.A. | ||
| 19.05. | Oryzon Genomics - Preparations in place for an active 2025 | Q125 saw Oryzon make significant headway towards Phase III for vafidemstat in BPD and clinical advancement for iadademstat across multiple early-stage studies. Operating performance was unsurprising... ► Artikel lesen | |
| 12.05. | Oryzon Genomics S.A. GAAP EPS of -$0.03 | ||
| 08.05. | Oryzon Genomics - €13.3m grant improves operating headroom | Oryzon Genomics has been awarded a €13.26m (US$15m) non-dilutive grant under the Med4Cure initiative, part of the Important Project of Common European Interest (IPCEI) framework, launched in May 2024.... ► Artikel lesen |
